Om

Kardigan Inc. is a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company works on targeted therapies designed to address the underlying disease mechanisms behind specific heart conditions, including cardiomyopathies that can lead to heart failure. Its current pipeline centers on clinical-stage cardiovascular programs aimed at diseases where approved treatment options remain limited or unavailable. Kardigan also uses a research and translational platform that combines clinical data, analytics, and precision medicine approaches to support drug discovery and development. The company operates as a single segment business centered on cardiovascular therapeutics and serves the broader healthcare and biotechnology market. Kardigan Inc. is headquartered in Princeton, New Jersey, and maintains its operational base in South San Francisco, California.

Analytikerskøn

Baseret på 4 analytikere

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I KARDIGAN MED ENDAVU: Køb Kardigan ($KARD) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Kardigan, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.